Showing results (101-110 of 379) with videos related to

Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|May 19, 2021
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysisJohannes F E Mann, John B Buse, Thomas Idorn, et al.
The Cochrane Database of Systematic Reviews|September 12, 2013
HMG CoA reductase inhibitors (statins) for dialysis patientsSuetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2020
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled TrialsAhmed M Shaman, Brendan Smyth, Clare Arnott, et al.
Kidney International Reports|October 27, 2025
Sex Differences Across Corticosteroid Response and Outcomes in IgA NephropathyDana Kim, Mark Woodward, Jicheng Lv, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 DiabetesMark E Cooper, Vlado Perkovic, Janet B McGill, et al.
American Journal of Nephrology|July 26, 2014
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathyHala Yamout, Vlado Perkovic, Melanie Davies, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2008
Proteinuria and stroke: a meta-analysis of cohort studiesToshiharu Ninomiya, Vlado Perkovic, Christine Verdon, et al.
Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.
Journal of Hypertension|December 13, 2018
Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuriaMark E Cooper, Vlado Perkovic, Per-Henrik Groop, et al.
Journal of the American College of Cardiology|September 11, 2010
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trialMeg J Jardine, Toshiharu Ninomiya, Vlado Perkovic, et al.
Pageof 38